[{"id":"48e3e199-7d3d-4fa6-85b3-d76b002c0a99","acronym":"","url":"https://clinicaltrials.gov/study/NCT01432145","created_at":"2021-01-18T05:55:05.610Z","updated_at":"2024-07-02T16:36:58.274Z","phase":"Phase 2","brief_title":"A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours","source_id_and_acronym":"NCT01432145","lead_sponsor":"University of Oxford","biomarkers":" BRCA1 • BRCA2 • BRCA","pipe":" | ","alterations":" BRCA2 mutation • BRCA1 mutation","tags":["BRCA1 • BRCA2 • BRCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA2 mutation • BRCA1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e mercaptopurine delayed release (DR6MP) • mercaptopurine"],"overall_status":"Completed","enrollment":" Enrollment 74","initiation":"Initiation: 05/01/2011","start_date":" 05/01/2011","primary_txt":" Primary completion: 12/01/2014","primary_completion_date":" 12/01/2014","study_txt":" Completion: 05/01/2015","study_completion_date":" 05/01/2015","last_update_posted":"2019-07-09"}]